sotagliflozin
sotagliflozin: 5 clinical trials tracked.
sotagliflozin evidence translation
What we can confirm
5 tracked trials
What it means
What to watch
Prepared research question
What is verified about sotagliflozin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (5)
A Phase 2 Double-blind Randomised Controlled Trial Studying the Effect of Sotagliflozin Versus Placebo in Individuals With Heart Failure and Type 1 Diabetes.
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score
Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
Primary endpoint: Number of participants with treatment-related adverse events
Effectiveness and Safety of Sotagliflozin in Slowing Kidney Function Decline in Persons With Type 1 Diabetes and Moderate to Severe Diabetic Kidney Disease
Primary endpoint: eGFR at the end of the wash-out period following the treatment period
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic Obstructive And Non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)
Primary endpoint: Change from Baseline to Week 26 in Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ CSS)
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
Primary endpoint: Change in HbA1c